Literature DB >> 9110298

Identical clonality of both components of mammary carcinosarcoma with differential loss of heterozygosity.

Z Zhuang1, R A Lininger, Y G Man, A Albuquerque, M J Merino, F A Tavassoli.   

Abstract

The histogenesis of carcinosarcomas is controversial, specifically with respect to clonality and cell of origin. To answer these questions, tumor cells from both epithelial and spindle-cell components were microdissected from three cases each of mammary carcinosarcoma and its postulated precursor, carcinoma with spindle-cell metaplasia. Clonality was assessed using the principle of X chromosome inactivation. Loss of heterozygosity (LOH) was evaluated at seven chromosomal loci to assess shared and distinctive genetic alterations for the two components in each tumor. All of the six cases demonstrated identical clonality of the carcinomatous and spindle-cell components, identical to a focus of ductal carcinoma in situ present in one case. LOH for NM23 was detected in both components in one carcinosarcoma, whereas LOH for INT-2 was detected in both components in one metaplastic carcinoma. Differential LOH for D11S904 was present in only the mesenchymal components of these two cases. We conclude that the two components of carcinosarcoma and its precursor are clonal and that the sarcomatous and spindle-cell components arise from mutation of the carcinoma. Presence of differential LOH at D11S904 in only the spindle-cell components suggests that this mutation might be critical to the development of this second phenotype.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9110298

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  10 in total

1.  Multiplex genotype analysis of invasive carcinoma and accompanying proliferative lesions microdissected from breast tissue.

Authors:  X Cui; H Feiner; Z Lin; H Li
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

Review 2.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

3.  Clonal origin and expansions in neoplasms: biologic and technical aspects must be considered together.

Authors:  Lucia Pozo-Garcia; Salvador J Diaz-Cano
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

4.  Whole-Exome Sequencing of Metaplastic Breast Carcinoma Indicates Monoclonality with Associated Ductal Carcinoma Component.

Authors:  Bracha Erlanger Avigdor; Katie Beierl; Christopher D Gocke; Daniel J Zabransky; Karen Cravero; Kelly Kyker-Snowman; Berry Button; David Chu; Sarah Croessmann; Rory L Cochran; Roisin M Connolly; Ben H Park; Sarah J Wheelan; Ashley Cimino-Mathews
Journal:  Clin Cancer Res       Date:  2017-04-19       Impact factor: 12.531

Review 5.  The epithelial-mesenchymal transition (EMT) phenomenon.

Authors:  P Savagner
Journal:  Ann Oncol       Date:  2010-10       Impact factor: 32.976

Review 6.  A Comparative Review of Mixed Mammary Tumors in Mammals.

Authors:  Eman S A Saad; Jacqueline S Y Lam; Awf A Al-Khan; Mourad Tayebi; Michael J Day; Samantha J Richardson; Janine A Danks
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-11-28       Impact factor: 2.673

Review 7.  Breast cancer stem cells, pathways and therapeutic perspectives 2011.

Authors:  Anjana Nigam
Journal:  Indian J Surg       Date:  2012-06-24       Impact factor: 0.656

8.  Transcription factor Snai1-1 induces osteosarcoma invasion and metastasis by inhibiting E-cadherin expression.

Authors:  Huiguang Yang; Yunqing Zhang; Zhengming Zhou; Xuefeng Jiang; Aidong Shen
Journal:  Oncol Lett       Date:  2014-04-22       Impact factor: 2.967

9.  Sarcomatoid (spindle cell) carcinoma of the pancreas: A case report and review of the literature.

Authors:  Joshua Robert Kane; William B Laskin; Kristina A Matkowskyj; Celina Villa; Anjana V Yeldandi
Journal:  Oncol Lett       Date:  2013-11-14       Impact factor: 2.967

10.  Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies.

Authors:  Theresa L Schwartz; Harveshp Mogal; Christos Papageorgiou; Jula Veerapong; Eddy C Hsueh
Journal:  Exp Hematol Oncol       Date:  2013-11-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.